![]() |
![]() | ![]() |
| We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level. |
The Wall Street Journal interviewed UNIVEC Sept. 28,1999 saying "Sales have risen from 745,000 in 1997 to a projeced 4.5 million in 1999. Its stock has gone from $10.13 to $0.18 per share, because on no visibilty". It is a GREAT company! Most states are mandating better syringes for health care workers and people that must use syringes (like diabetics) and yet the stock isn't being retailed. ANY QUESTIONS? I have read about the large percentage of death prevention with this product from diseases like HIV and Hepatitis C. Look at the stock it is just sitting there at affordable prices.
| ||||||||||||
|
| Home | Hot | SubjectMarks | PeopleMarks | Keepers | Settings |
| Terms Of Use | Contact Us | Copyright/IP Policy | Privacy Policy | About Us | FAQ | Advertise on SI |
| © 2025 Knight Sac Media. Data provided by Twelve Data, Alpha Vantage, and CityFALCON News |